글로버스메디컬(주)
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership107,099 shares
Latest Disclosed Value $ 9,227,646
Stifel Financial Corp reports 44.13% increase in ownership of GMED / Globus Medical, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 107,099 shares of Globus Medical, Inc. (MX:GMED) valued at $9,227,646 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 74,309 shares of Globus Medical, Inc.. This represents a change in shares of 44.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GLOBUS MED CL A 379577208 107,099 32,790 44.13 9,228 42.24 0.0020
2026-02-13 2025-12-31 13F GLOBUS MED CL A 379577208 74,309 -88,997 -54.50 6,488 -30.64 0.0058
2025-11-12 2025-09-30 13F GLOBUS MED CL A 379577208 163,306 81,125 98.72 9,353 92.82 0.0085
2025-08-14 2025-06-30 13F GLOBUS MED CL A 379577208 82,181 12,112 17.29 4,850 -5.44 0.0047
2025-05-14 2025-03-31 13F GLOBUS MED CL A 379577208 70,069 12,435 21.58 5,129 7.62 0.0055
2025-02-13 2024-12-31 13F GLOBUS MED CL A 379577208 57,634 4,799 9.08 4,767 26.12 0.0050
2024-11-14 2024-09-30 13F GLOBUS MED CL A 379577208 52,835 306 0.58 3,780 5.06 0.0040
2024-08-13 2024-06-30 13F GLOBUS MED CL A 379577208 52,529 6,714 14.65 3,598 46.40 0.0040
2024-05-14 2024-03-31 13F GLOBUS MED CL A 379577208 45,815 6,125 15.43 2,458 16.17 0.0028
2024-02-12 2023-12-31 13F GLOBUS MED CL A 379577208 39,690 -7,532 -15.95 2,115 -9.77 0.0027
2023-11-13 2023-09-30 13F GLOBUS MED CL A 379577208 47,222 42,535 907.51 2,345 740.14 0.0033
2023-08-14 2023-06-30 13F GLOBUS MED CL A 379577208 4,687 -493 -9.52 279 -4.78 0.0004
2023-05-12 2023-03-31 13F GLOBUS MED CL A 379577208 5,180 -198,575 -97.46 293 -98.06 0.0004
2023-02-13 2022-12-31 13F GLOBUS MED CL A 379577208 203,755 66,442 48.39 15,133 84.99 0.0227
2022-11-14 2022-09-30 13F GLOBUS MED CL A 379577208 137,313 -22,163 -13.90 8,180 -8.64 0.0134
2022-08-15 2022-06-30 13F GLOBUS MED CL A 379577208 159,476 131,325 466.50 8,954 331.10 0.0140
2022-05-13 2022-03-31 13F GLOBUS MED CL A 379577208 28,151 1,983 7.58 2,077 9.95 0.0028
2022-02-14 2021-12-31 13F GLOBUS MED CL A 379577208 26,168 168 0.65 1,889 -5.17 0.0025
2021-11-15 2021-09-30 13F GLOBUS MED CL A 379577208 26,000 21,729 508.76 1,992 501.81 0.0029
2021-08-13 2021-06-30 13F GLOBUS MED CL A 379577208 4,271 4,271 331 0.0005
2020-05-14 2020-03-31 13F GLOBUS MED CL A 379577208 0 -7,142 -100.00 0 -100.00
2020-02-13 2019-12-31 13F GLOBUS MED CL A 379577208 7,142 819 12.95 418 29.01 0.0009
2019-11-19 2019-09-30 13F/A-1 GLOBUS MED CL A 379577208 6,323 -5,917 -48.34 324 -37.57 0.0008
2019-11-13 2019-09-30 13F GLOBUS MED CL A 379577208 6,323 -5,917 324 181.6182
2019-08-14 2019-06-30 13F GLOBUS MED CL A 379577208 12,240 -2,783 -18.52 519 -30.05 0.0013
2019-05-14 2019-03-31 13F GLOBUS MED CL A 379577208 15,023 9,823 188.90 742 229.78 0.0021
2019-02-13 2018-12-31 13F GLOBUS MED CL A 379577208 5,200 0 0.00 225 -23.73 0.0007
2018-11-13 2018-09-30 13F GLOBUS MED CL A 379577208 5,200 -67 -1.27 295 11.32 0.0008
2018-08-14 2018-06-30 13F GLOBUS MED CL A 379577208 5,267 -7,488 -58.71 265 -58.27 0.0008
2018-05-11 2018-03-31 13F GLOBUS MED CL A 379577208 12,755 -7,142 -35.89 635 -21.80 0.0020
2018-02-14 2017-12-31 13F GLOBUS MED CL A 379577208 19,897 4,270 27.32 812 76.14 0.0026
2017-11-13 2017-09-30 13F GLOBUS MED CL A 379577208 15,627 -820 -4.99 461 -15.26 0.0016
2017-08-14 2017-06-30 13F GLOBUS MED CL A 379577208 16,447 -6,165 -27.26 544 -18.56 0.0020
2017-05-10 2017-03-31 13F GLOBUS MED CL A 379577208 22,612 -33 -0.15 668 19.29 0.0026
2017-02-16 2016-12-31 13F GLOBUS MED CL A 379577208 22,645 7,262 47.21 560 60.92 0.0024
2016-11-15 2016-09-30 13F GLOBUS MED CL A 379577208 15,383 15,383 -32.07 348 -37.86 0.0016
2016-05-16 2016-03-31 13F GLOBUS MED CL A 379577208 0 -4,096 -100.00 0 -100.00
2016-02-16 2015-12-31 13F GLOBUS MED CL A 379577208 4,096 4,096 1,287 0.0059
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.